Funded Tech Companies
Alphyn Biologics
Alphyn Biologics, operating out of Annapolis, received investment capital through Serial Stage Venture Partners, Angel Physicians Fund and Queen City Angels.
Company Overview
Company Name
Alphyn Biologics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
3724 Thomas Point Road
Annapolis, MD Undisclosed
USA
Annapolis, MD Undisclosed
USA
Phone
Website
Email Address
Company Background Information
Overview
Alphyn is using its patent pending AB-101 platform biomaterial to target the most difficult, severe and prevalent skin diseases facing humankind. AB-101's first target disease is Atopic Dermatitis (or AD, also known as Eczema). AD is difficult to treat, can be very severe for many people and affects millions of people worldwide. A solution for AD is clearly needed.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
9/19/2022
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Neal Koller
Chief Scientific Officer
Gary Pekoe
President
Steven Pentelnik
Company Investors
- Serial Stage Venture Partners
- Angel Physicians Fund
- Queen City Angels
Browse more funded tech companies:
Share this article
About Our VC & M&A Database
Our data comes from VentureDeal.com, a leading supplier of venture capital funding data.
Additional Resources for Entrepreneurs